Case number 2017-1052
Daiichi Sankyo Company, Ltd. v. Accord Healthcare Inc., USA > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | DAIICHI SANKYO COMPANY, LTD. v. ACCORD HEALTHCARE INC., USA [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Feb 21, 2018 | 86 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by Clerk of Court. [499610] [17-1052, 17-1053] [JAB] [Entered: 02/21/2018 09:07 AM] (0) |
| Feb 14, 2018 | 85 | ORDER filed denying [83] petition for panel rehearing filed by Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.; denying [83] petition for en banc rehearing filed by Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [497669] [SJ] [Entered: 02/14/2018 01:46 PM] (0) |
| Jan 12, 2018 | 84 | 18 paper copies of the petition for panel rehearing [83], petition for en banc rehearing [83] received from Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. [489836] [SJ] [Entered: 01/16/2018 03:31 PM] (0) |
| Jan 11, 2018 | 83 | Petition for panel rehearing, for en banc rehearing filed by Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. Service: 01/11/2018 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 01/16/2018 [489166] [Christopher Suarez] [Entered: 01/11/2018 04:38 PM] (0) |
| Dec 12, 2017 | 82 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (FCR 36). (For the Court: Lourie,Circuit Judge; O'Malley,Circuit Judge and Wallach,Circuit Judge). [481880] [17-1052, 17-1053] [SJ] [Entered: 12/12/2017 09:30 AM] (0) |
| Dec 8, 2017 | 81 | Submitted after ORAL ARGUMENT by Adam Lawrence Perlman for Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. and George C. Lombardi for Accord Healthcare Inc., USA, Accord Healthcare, Inc., Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Apotex Corp., Apotex Inc., Cadila Healthcare Ltd., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., Lupin Pharmaceuticals, Inc., Panacea Biotec Ltd., Sun Pharma Global FZE, Teva Pharmaceuticals USA, Inc. and Zydus Pharmaceuticals USA, Inc. Panel: Judge: Lourie , Judge: O'Malley , Judge: Wallach. [481159] [JAB] [Entered: 12/08/2017 10:22 AM] (0) |
| Nov 14, 2017 | 80 | Response to oral argument order from the Appellees Accord Healthcare Inc., USA, Accord Healthcare, Inc., Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Apotex Corp., Apotex Inc., Cadila Healthcare Ltd., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., Lupin Pharmaceuticals, Inc., Panacea Biotec Ltd., Sun Pharma Global FZE, Teva Pharmaceuticals USA, Inc. and Zydus Pharmaceuticals USA, Inc.. designating George C. Lombardi as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [475534] [George Lombardi] [Entered: 11/14/2017 06:32 PM] (0) |
| Oct 30, 2017 | 79 | Response to oral argument order from the Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. designating Adam L. Perlman as arguing attorney. Designated time for argument: 11 minutes. Designated time for rebuttal: 4 minutes. Service of other counsel by Notice of Docket Activity from this entry. [471406] [Adam Perlman] [Entered: 10/30/2017 02:03 PM] (0) |
| Oct 20, 2017 | 78 | NOTICE OF CALENDARING. Panel: 1712N. Case scheduled Dec 08, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 11/15/2017. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [469439] [JAB] [Entered: 10/20/2017 01:08 PM] (0) |
| Jun 14, 2017 | 77 | Notice from Appellees Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Apotex Corp., Apotex Inc., Panacea Biotec Ltd., Sun Pharma Global FZE and Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument (August 7, August 9, September 5, and during the October Court week (October 2-6)). Service: 06/14/2017 by email. [439349] [George Lombardi] [Entered: 06/14/2017 06:38 PM] (0) |
| Apr 25, 2017 | 76 | Notice from Appellees Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Apotex Corp., Apotex Inc., Panacea Biotec Ltd., Sun Pharma Global FZE and Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument (June court week (June 5-9), August 7 and September 5-6). Service: 04/25/2017 by email. [427088] [George Lombardi] [Entered: 04/25/2017 06:24 PM] (2) |
| Apr 24, 2017 | 75 | Notice from Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. regarding conflicts with oral argument (Supplemental notice: July 10 and 11, 2017; October and November 2017 court weeks). Service: 04/24/2017 by email. [426710] [Christopher Suarez] [Entered: 04/24/2017 04:58 PM] (1) |
| Apr 20, 2017 | 74 | Notice from Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. regarding conflicts with oral argument (October 2017 and November 2017 court weeks). Service: 04/20/2017 by email. [425917] [Christopher Suarez] [Entered: 04/20/2017 03:27 PM] (1) |
| Apr 14, 2017 | 73 | 6 paper copies of the Joint Appendix (Vol. I-IV) [69] received from Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. [424280] [KW] [Entered: 04/14/2017 02:18 PM] (0) |
| Apr 13, 2017 | 72 | CORRECTED certificate of service for Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. for Brief , Doc No. [68]. Service: 04/13/2017 by email. [423817] [Christopher Suarez] [Entered: 04/13/2017 01:03 PM] (3) |
| Apr 13, 2017 | 71 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks (June 2017, July 2017, August 2017), or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 04/20/2017. [423775] [JCA] [Entered: 04/13/2017 11:16 AM] (0) |
| Apr 13, 2017 | 70 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:appendix Brief Docket No. [69], ERROR: The tendered appendix did not include a certificate of service. CORRECTION: Counsel should use the Event Category- Forms and Certificates, Event- Corrected Certificate of Service to file a Certificate of Service for the appendix reflecting a service date of 4/12/17. There is no need to retender the appendix. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [423772] [JCA] [Entered: 04/13/2017 11:13 AM] (0) |
| Apr 12, 2017 | 69 | APPENDIX FILED for Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. [68]. Number of Pages: 1657. Service: 04/12/2017 by email. The paper copies of the brief should be received by the court on or before 04/20/2017. [423768] [JCA] [Entered: 04/13/2017 11:09 AM] (1657) |
| Apr 12, 2017 | 68 | TENDERED from Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. Title: JOINT APPENDIX. Service: 04/12/2017 by email. [423658] [Christopher Suarez] [Entered: 04/12/2017 08:48 PM] (1657) |
| Apr 6, 2017 | 67 | 6 paper copies of the Reply Brief [66] received from Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. [422421] [KW] [Entered: 04/07/2017 01:55 PM] (0) |
| Apr 5, 2017 | 66 | REPLY BRIEF FILED for Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. [65]. Number of Pages: 31. Service: 04/05/2017 by email. The paper copies of the brief should be received by the court on or before 04/13/2017. Appendix is due 04/12/2017. [421911] [JCA] [Entered: 04/06/2017 09:13 AM] (38) |
| Apr 5, 2017 | 65 | TENDERED from Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. Title: REPLY BRIEF. Service: 04/05/2017 by email. [421841] [Christopher Suarez] [Entered: 04/05/2017 05:06 PM] (38) |
| Mar 13, 2017 | 64 | 6 paper copies of the Response Brief [58] received from Appellees Accord Healthcare Inc., USA, Accord Healthcare, Inc., Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, et al. [415317] [KW] [Entered: 03/14/2017 01:58 PM] (0) |
| Mar 13, 2017 | 63 | **TEXT ONLY** ORDER granting motion to withdraw attorney Sara Kaiser Creighton [61] filed by Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [415047] [JCA] [Entered: 03/13/2017 04:34 PM] (0) |
| Mar 13, 2017 | 62 | **TEXT ONLY** ORDER granting motion to extend time to file reply brief [60] filed by Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. Reply brief is due 04/05/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [415044] [JCA] [Entered: 03/13/2017 04:32 PM] (0) |
| Mar 13, 2017 | 61 | MOTION of Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. to withdraw counsel Sara K. Creighton. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/13/2017 by email. [415020] [Christopher Suarez] [Entered: 03/13/2017 04:12 PM] (5) |
| Mar 13, 2017 | 60 | MOTION of Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. to extend the time to 04/05/2017 to file the reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/13/2017 by email. [415015] [Christopher Suarez] [Entered: 03/13/2017 04:11 PM] (5) |
| Mar 9, 2017 | 59 | ORDER filed. The motion [56] is granted. The revised official caption is reflected in the order. Service: 03/09/2017 by clerk. [413997] [LMS] [Entered: 03/09/2017 02:59 PM] (2) |
| Mar 8, 2017 | 58 | BRIEF FILED for Appellees Accord Healthcare Inc., USA, Accord Healthcare, Inc., Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Apotex Corp., Apotex Inc., Cadila Healthcare Ltd., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., Lupin Pharmaceuticals, Inc., Panacea Biotec Ltd., Sun Pharma Global FZE, Teva Pharmaceuticals USA, Inc. and Zydus Pharmaceuticals USA, Inc. [57]. Number of Pages: 64. Service: 03/08/2017 by email. The paper copies of the brief should be received by the court on or before 03/16/2017. Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. reply brief is due 03/22/2017. [413734] [JCA] [Entered: 03/09/2017 09:24 AM] (86) |
| Mar 8, 2017 | 57 | TENDERED from Appellees Accord Healthcare Inc., USA, Accord Healthcare, Inc., Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Apotex Corp., Apotex Inc., Cadila Healthcare Ltd., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., Lupin Pharmaceuticals, Inc., Panacea Biotec Ltd., Sun Pharma Global FZE, Teva Pharmaceuticals USA, Inc. and Zydus Pharmaceuticals USA, Inc.. Title: RESPONSE BRIEF. Service: 03/08/2017 by email. [413597] [Samuel Park] [Entered: 03/08/2017 04:33 PM] (86) |
| Mar 6, 2017 | 56 | MOTION of Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. to withdraw party, Glenmark Pharmaceuticals USA, Inc. and Glenmark Pharmaceuticals Ltd., as a party to this appeal. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/06/2017 by email. [412828] [Adam Perlman] [Entered: 03/06/2017 04:36 PM] (6) |
| Mar 3, 2017 | 55 | Notice of Rejection to Appellants Daiichi Sankyo Company, Ltd., Ube Industries Ltd. and Appellees Glenmark Pharmaceuticals Inc., USA and Glenmark Pharmaceuticals Ltd., the following document(s): motion to withdraw party [54] is REJECTED for filing. Reason(s): See Attached. Service: 03/03/2017 by. [412259] [JCA] [Entered: 03/03/2017 10:10 AM] (1) |
| Mar 3, 2017 | 54 | MOTION of Appellants Daiichi Sankyo Company, Ltd., Ube Industries Ltd. and Appellees Glenmark Pharmaceuticals Inc., USA and Glenmark Pharmaceuticals Ltd. to withdraw party, Glenmark Pharmaceuticals USA, Inc. and Glenmark Pharmaceuticals Ltd., as a party to this appeal. Any response is due within 10 days of service [Consent: not addressed]. Service: 03/03/2017 by email. [412222] [Adam Perlman] [Entered: 03/03/2017 09:24 AM] (4) |
| Mar 3, 2017 | 53 | Notice of Rejection to Appellants Daiichi Sankyo Company, Ltd., Ube Industries Ltd. and Appellees Glenmark Pharmaceuticals Inc., USA and Glenmark Pharmaceuticals Ltd., the following document(s) cannot be filed: [52] party document. Reason(s) See Attached. [412196] [JCA] [Entered: 03/03/2017 08:50 AM] (1) |
| Mar 2, 2017 | 52 | Stipulation of Dismissal as to Glenmark Pharmaceuticals USA, Inc. and Glenmark Pharmaceuticals Ltd. for Appellants Daiichi Sankyo Company, Ltd., Ube Industries Ltd. and Appellees Glenmark Pharmaceuticals Inc., USA and Glenmark Pharmaceuticals Ltd.. Service: 03/01/2017 by email. [412148]. This document has rejected. See Doc No.[53] [Adam Perlman] [Entered: 03/02/2017 05:53 PM] (0) |
| Jan 30, 2017 | 51 | 6 paper copies of the Opening Brief [50] received from Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. [403408] [KW] [Entered: 01/31/2017 01:25 PM] (0) |
| Jan 27, 2017 | 50 | BRIEF FILED for Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd. [49]. Number of Pages: 52. Service: 01/27/2017 by email. The paper copies of the brief should be received by the court on or before 02/06/2017. Appellees Accord Healthcare Inc., USA, Accord Healthcare, Inc., et al. brief is due 03/08/2017. [402996] [JCA] [Entered: 01/30/2017 12:15 PM] (165) |
| Jan 27, 2017 | 49 | TENDERED from Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. Title: OPENING BRIEF. Service: 01/27/2017 by email. [402837] [Adam Perlman] [Entered: 01/27/2017 08:16 PM] (165) |
| Nov 28, 2016 | 48 | Certified List from the United States Patent and Trademark Office. Service: 11/28/2016 by email. Appellant/Petitioner's brief is due 01/27/2017. [386344] [17-1052, 17-1053] [JCA] [Entered: 11/28/2016 03:35 PM] (115) |
| Nov 2, 2016 | 47 | ORDER filed. The motion [14] is granted. The revised official caption is reflected in the order. Service: 11/02/2016 by clerk. [379619] [LMS] [Entered: 11/02/2016 12:01 PM] (2) |
| Oct 31, 2016 | 32 | Entry of appearance for Christopher A. Suarez as of counsel for Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. Service: 10/31/2016 by email. [378831] [Christopher Suarez] [Entered: 10/31/2016 01:40 PM] (2) |
| Oct 31, 2016 | 33 | Certificate of Interest for the Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. Service: 10/31/2016 by email. [378832] [Christopher Suarez] [Entered: 10/31/2016 01:41 PM] (2) |
| Oct 31, 2016 | 40 | Entry of appearance for George C. Lombardi as principal counsel for Appellees Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Apotex Corp., Apotex Inc., Panacea Biotec Ltd., Sun Pharma Global FZE and Teva Pharmaceuticals USA, Inc.. Service: 10/31/2016 by email. [378991] [George Lombardi] [Entered: 10/31/2016 04:14 PM] (2) |
| Oct 31, 2016 | 35 | Entry of appearance for Douglass C. Hochstetler as principal counsel for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 10/31/2016 by email. [378958] [Douglass Hochstetler] [Entered: 10/31/2016 03:41 PM] (2) |
| Oct 31, 2016 | 36 | Certificate of Interest for the Appellee Lupin Ltd.. Service: 10/31/2016 by email. [378961] [Douglass Hochstetler] [Entered: 10/31/2016 03:44 PM] (2) |
| Oct 31, 2016 | 37 | Certificate of Interest for the Appellee Lupin Pharmaceuticals, Inc.. Service: 10/31/2016 by email. [378963] [Douglass Hochstetler] [Entered: 10/31/2016 03:45 PM] (2) |
| Oct 31, 2016 | 38 | Docketing Statement for the Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 10/31/2016 by email. [378967] [Douglass Hochstetler] [Entered: 10/31/2016 03:48 PM] (3) |
| Oct 31, 2016 | 39 | Entry of appearance for Clifford Katz as of counsel for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 10/31/2016 by email. [378973] [Clifford Katz] [Entered: 10/31/2016 03:53 PM] (2) |
| Oct 31, 2016 | 34 | Docketing Statement for the Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. Service: 10/31/2016 by email. [378835] [Christopher Suarez] [Entered: 10/31/2016 01:42 PM] (4) |
| Oct 31, 2016 | 41 | Entry of appearance for Samuel S. Park as of counsel for Appellees Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Apotex Corp., Apotex Inc., Panacea Biotec Ltd., Sun Pharma Global FZE and Teva Pharmaceuticals USA, Inc.. Service: 10/31/2016 by email. [378996] [Samuel Park] [Entered: 10/31/2016 04:20 PM] (2) |
| Oct 31, 2016 | 42 | Docketing Statement for the Appellees Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Apotex Corp., Apotex Inc., Panacea Biotec Ltd., Sun Pharma Global FZE and Teva Pharmaceuticals USA, Inc.. Service: 10/31/2016 by email. [378998] [Samuel Park] [Entered: 10/31/2016 04:22 PM] (3) |
| Oct 31, 2016 | 43 | Certificate of Interest for the Appellees Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Apotex Corp., Apotex Inc., Panacea Biotec Ltd., Sun Pharma Global FZE and Teva Pharmaceuticals USA, Inc.. Service: 10/31/2016 by email. [379001] [Samuel Park] [Entered: 10/31/2016 04:24 PM] (5) |
| Oct 31, 2016 | 44 | Entry of appearance for Charles B. Klein as of counsel for Appellees Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Apotex Corp., Apotex Inc., Panacea Biotec Ltd., Sun Pharma Global FZE and Teva Pharmaceuticals USA, Inc.. Service: 10/31/2016 by email. [379006] [Charles Klein] [Entered: 10/31/2016 04:28 PM] (2) |
| Oct 31, 2016 | 45 | Entry of appearance for Maureen L. Rurka as of counsel for Appellees Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Apotex Corp., Apotex Inc., Panacea Biotec Ltd., Sun Pharma Global FZE and Teva Pharmaceuticals USA, Inc.. Service: 10/31/2016 by email. [379011] [Maureen Rurka] [Entered: 10/31/2016 04:31 PM] (2) |
| Oct 31, 2016 | 46 | Entry of appearance for Eimeric Reig-Plessis as of counsel for Appellees Amneal Pharmaceuticals Co. India Pvt. Ltd., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Apotex Corp., Apotex Inc., Panacea Biotec Ltd., Sun Pharma Global FZE and Teva Pharmaceuticals USA, Inc.. Service: 10/31/2016 by email. [379013] [Eimeric Reig-Plessis] [Entered: 10/31/2016 04:35 PM] (2) |
| Oct 31, 2016 | 31 | Entry of appearance for Sarah Kaiser Creighton as of counsel for Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. Service: 10/31/2016 by email. [378829] [Christopher Suarez] [Entered: 10/31/2016 01:39 PM] (2) |
| Oct 31, 2016 | 30 | Docketing Statement for the Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 10/31/2016 by email. [378828] [Paul Kochanski] [Entered: 10/31/2016 01:38 PM] (5) |
| Oct 31, 2016 | 29 | Entry of appearance for Allison Jones as of counsel for Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. Service: 10/31/2016 by email. [378827] [Christopher Suarez] [Entered: 10/31/2016 01:37 PM] (2) |
| Oct 31, 2016 | 28 | Entry of appearance for David M. Krinsky as of counsel for Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. Service: 10/31/2016 by email. [378824] [Christopher Suarez] [Entered: 10/31/2016 01:36 PM] (2) |
| Oct 31, 2016 | 27 | Certificate of Interest for the Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 10/31/2016 by email. [378823] [Paul Kochanski] [Entered: 10/31/2016 01:35 PM] (3) |
| Oct 31, 2016 | 26 | Entry of appearance for Dov P. Grossman as of counsel for Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. Service: 10/31/2016 by email. [378822] [Christopher Suarez] [Entered: 10/31/2016 01:34 PM] (2) |
| Oct 31, 2016 | 25 | Entry of appearance for Adam L. Perlman as principal counsel for Appellants Daiichi Sankyo Company, Ltd. and Ube Industries Ltd.. Service: 10/31/2016 by email. [378821] [Christopher Suarez] [Entered: 10/31/2016 01:33 PM] (2) |
| Oct 31, 2016 | 24 | Entry of appearance for William L. Mentlik as principal counsel for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 10/31/2016 by email. [378817] [William Mentlik] [Entered: 10/31/2016 01:30 PM] (3) |
| Oct 31, 2016 | 23 | Entry of appearance for Paul H. Kochanski as of counsel for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 10/31/2016 by email. [378813] [Paul Kochanski] [Entered: 10/31/2016 01:26 PM] (3) |
| Oct 31, 2016 | 22 | Certificate of Interest for the Appellees Accord Healthcare Inc., USA, Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd.. Service: 10/31/2016 by email. [378783] [Michael Dzwonczyk] [Entered: 10/31/2016 12:03 PM] (1) |
| Oct 31, 2016 | 21 | Docketing Statement for the Appellees Accord Healthcare Inc., USA, Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd.. Service: 10/31/2016 by email. [378781] [Michael Dzwonczyk] [Entered: 10/31/2016 12:02 PM] (3) |
| Oct 31, 2016 | 20 | Entry of appearance for Azadeh S. Kokabi as of counsel for Appellees Accord Healthcare Inc., USA, Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd.. Service: 10/31/2016 by email. [378779] [Michael Dzwonczyk] [Entered: 10/31/2016 12:01 PM] (1) |
| Oct 31, 2016 | 19 | Entry of appearance for Michael R. Dzwonczyk as principal counsel for Appellees Accord Healthcare Inc., USA, Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd.. Service: 10/31/2016 by email. [378777] [Michael Dzwonczyk] [Entered: 10/31/2016 11:59 AM] (1) |
| Oct 31, 2016 | 18 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: docketing statement Docket No. [17], certificate of interest Docket No. [16], attorney entry of appearance Docket No. [15], ERROR: These documents do not list appeal number 17-1053. CORRECTION: Counsel is reminded that future filings should include 17-1052 and 17-1053 as case numbers. There is no need to refile these documents. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [378741] [JCA] [Entered: 10/31/2016 11:26 AM] (0) |
| Oct 31, 2016 | 17 | Docketing Statement for the Appellees Cadila Healthcare Ltd. and Zydus Pharmaceuticals USA, Inc.. Service: 10/30/2016 by email. [378592] [Steven Moore] [Entered: 10/30/2016 09:49 PM] (5) |
| Oct 31, 2016 | 16 | Certificate of Interest for the Appellees Cadila Healthcare Ltd. and Zydus Pharmaceuticals USA, Inc.. Service: 10/30/2016 by email. [378591] [Steven Moore] [Entered: 10/30/2016 09:47 PM] (3) |
| Oct 31, 2016 | 15 | Entry of appearance for Steven J. Moore, Esq. as principal counsel for Appellees Cadila Healthcare Ltd. and Zydus Pharmaceuticals USA, Inc.. Service: 10/30/2016 by email. [378590] [Steven Moore] [Entered: 10/30/2016 09:45 PM] (3) |
| Oct 28, 2016 | 14 | MOTION of Appellees Glenmark Generics Inc., USA, Glenmark Generics Ltd. and Glenmark Pharmaceuticals Ltd. to modify the official caption. Response/Opposition is due 11/07/2016 [Consent: unopposed]. Service: 10/28/2016 by email. [378549] [Kevin Nelson] [Entered: 10/28/2016 04:56 PM] (18) |
| Oct 28, 2016 | 13 | Docketing Statement for the Appellees Glenmark Generics Inc., USA, Glenmark Generics Ltd. and Glenmark Pharmaceuticals Ltd.. Service: 10/28/2016 by email. [378544] [Kevin Nelson] [Entered: 10/28/2016 04:49 PM] (5) |
| Oct 28, 2016 | 12 | Certificate of Interest for the Appellees Glenmark Generics Inc., USA, Glenmark Generics Ltd. and Glenmark Pharmaceuticals Ltd.. Service: 10/28/2016 by email. [378543] [Kevin Nelson] [Entered: 10/28/2016 04:48 PM] (3) |
| Oct 28, 2016 | 11 | Entry of appearance for Patrick C. Gallagher as of counsel for Appellees Glenmark Generics Inc., USA, Glenmark Generics Ltd. and Glenmark Pharmaceuticals Ltd.. Service: 10/28/2016 by email. [378542] [Kevin Nelson] [Entered: 10/28/2016 04:47 PM] (3) |
| Oct 28, 2016 | 10 | Entry of appearance for Kevin M. Nelson as principal counsel for Appellees Glenmark Generics Inc., USA, Glenmark Generics Ltd. and Glenmark Pharmaceuticals Ltd.. Service: 10/28/2016 by email. [378539] [Kevin Nelson] [Entered: 10/28/2016 04:45 PM] (3) |
| Oct 28, 2016 | 9 | Notice of Rejection to Appellees Glenmark Generics Inc., USA, Glenmark Generics Ltd. and Glenmark Pharmaceuticals Ltd., the following document(s) cannot be filed: entries of appearance [5] and [6], docketing statement [7], certificate of interest [8]. Reasons: See attached Notice of Rejection. Corrected documents due 11/07/2016. [378273] [CMP] [Entered: 10/28/2016 10:17 AM] (2) |
| Oct 27, 2016 | 8 | Certificate of Interest for the Appellees Glenmark Generics Inc., USA and Glenmark Pharmaceuticals Ltd.. Service: 10/27/2016 by email. [378156] This document has been rejected. See Doc No.[9]. [Kevin Nelson] [Entered: 10/27/2016 04:01 PM] (0) |
| Oct 27, 2016 | 7 | Docketing Statement for the Appellees Glenmark Generics Inc., USA and Glenmark Pharmaceuticals Ltd.. Service: 10/27/2016 by email. [378152] This document has been rejected. See Doc No.[9]. [Kevin Nelson] [Entered: 10/27/2016 04:00 PM] (0) |
| Oct 27, 2016 | 6 | Entry of appearance for Patrick C. Gallagher as of counsel for Appellees Glenmark Generics Inc., USA and Glenmark Pharmaceuticals Ltd.. Service: 10/27/2016 by email. [378148] This document has been rejected. See Doc No. [9]. [Kevin Nelson] [Entered: 10/27/2016 03:58 PM] (0) |
| Oct 27, 2016 | 5 | Entry of appearance for Kevin M. Nelson as principal counsel for Appellees Glenmark Generics Inc., USA and Glenmark Pharmaceuticals Ltd.. Service: 10/27/2016 by email. [378147] This document has been rejected. See Doc No. [9]. [Kevin Nelson] [Entered: 10/27/2016 03:56 PM] (0) |
| Oct 19, 2016 | 4 | Note to file: The following cases are associated:17-1052 Lead with 17-1053 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [376007] [17-1052, 17-1053] [JCA] [Entered: 10/19/2016 04:22 PM] (0) |
| Oct 19, 2016 | 3 | ORDER consolidating appeals (17-1052, 17-1053). Service as of this date by Clerk of Court. [376002] [17-1052, 17-1053] [JCA] [Entered: 10/19/2016 04:18 PM] (2) |
| Oct 18, 2016 | 2 | Amended Notice of Appeal for Daiichi Sankyo Co., Ltd. and Ube Industries, Ltd.. Service: 10/18/2016 by email. [375667] [JCA] [Entered: 10/19/2016 09:19 AM] (8) |
| Oct 17, 2016 | 1 | Appeal docketed. Received: 10/11/2016. [374686] Entry of Appearance due 10/31/2016. Certificate of Interest is due on 10/31/2016. Docketing Statement due 10/31/2016. Certified List due on 11/28/2016. [JCA] [Entered: 10/17/2016 10:15 AM] (45) |
